Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Phoenix AZ, Tucson AZ, La Jolla CA, Orange CA,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
US National OCS Heart Perfusion (OHP) Registry
for
Heart Transplant
Location: Phoenix AZ, La Jolla CA, Salt Lake City UT, Boulder CO,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05915299
Recruiting
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Phoenix AZ, Tucson AZ, San Diego CA, La Jolla CA,
Sponsor: Translational Sciences, Inc.
Sex: All
Age: 18+
Code: NCT05948566
Phase 2, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Phoenix AZ, San Marcos CA, San Diego CA, La Jolla CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Phoenix AZ, Orange CA, Long Beach CA, Los Angeles CA,
Sponsor: University of Michigan
Sex: All
Age: 0 - 17
Code: NCT05376267
Recruiting
MSC EVs in Dystrophic Epidermolysis Bullosa
for
Dystrophic Epidermolysis Bullosa
Location: Phoenix AZ, Los Angeles CA, Philadelphia PA
Sponsor: Aegle Therapeutics
Sex: All
Age: 0+
Code: NCT04173650
Phase 1, Phase 2, Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
for
Ulcerative Colitis, Crohn's Disease
Location: Phoenix AZ, Park Ridge IL, Roanoke VA
Sponsor: Takeda
Sex: All
Age: 2+
Code: NCT05442567
Phase 3, Recruiting
Digoxin Medulloblastoma Study
for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Phoenix AZ, Dallas TX, Little Rock AR, St Louis MO,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 1 - 30
Code: NCT06701812
Phase 2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue